Place of agonists Imidazol(in)e Receptors in arterial hypertension patients therapy

Place of agonists Imidazol(in)e Receptors in arterial hypertension patients therapy

.

Saved in:

Bibliographic Details
Main Authors:	A. N. Britov, O. A. Orlova
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2006-02-01
Series:	Российский кардиологический журнал
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1709
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Place of imidazoline receptor agonists in the treatment of arterial hypertension
by: D. V. Nebieridze, et al.
Published: (2023-12-01)

PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY
by: S. A. Boytsov, et al.
Published: (2016-01-01)

Patient and disease characteristics of pulmonary arterial hypertension patients for prostacyclin receptor agonist selexipag treatment initiation
by: E. A. Rezukhina, et al.
Published: (2023-03-01)

Personalized approach to the treatment of patients with arterial hypertension: focus on imidazoline receptor agonists. Opinion on the problem
by: E. I. Baranova, et al.
Published: (2025-03-01)

An imidazoline receptor agonist, moxonidine, in optimization of arterial hypertension treatment among postmenopausal women
by: A. B. Bakhshaliev, et al.
Published: (2006-02-01)

Imidazoline receptor agonist moxonidine and arterial hypertension treatment in women with menopausal metabolic syndrome
by: E. V. Tishina, et al.
Published: (2011-06-01)

HIGHLY SELECTIVE BETA-ADRENOBLOCKER BISOPROLOL IN THE TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND ASSOCIATED CLINICAL CONDITIONS
by: A. N. Britov
Published: (2011-08-01)

Zeolites and zeolite imidazole frameworks in pharmacy (review)
by: E. O. Bakhrushina, et al.
Published: (2025-03-01)

Some hormonal systems in males with arterial hypertension and metabolic syndrome
by: A. N. Britov, et al.
Published: (2006-06-01)

A STUDY OF MOXONIDINE’S METABOLIC EFFECTS IN PATIENTS WITH ARTERIAL HYPERTENSION AND NIDDM
by: D. V. Nebieridze, et al.
Published: (2001-04-01)

Angiotensin receptor-1 antagonist eprosartan in patients with mild to moderate arterial hypertension
by: A. V. Shabalin, et al.
Published: (2005-12-01)

COMPARATIVE EFFICACY OF LONG-TERM ANTIHYPERTENSIVE MONOTHERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AT THE WORK PLACE
by: О. N. Antropova, et al.
Published: (2016-01-01)

OPPORTUNITIES FOR OPTIMIZATION OF DRUG THERAPY BY ENDOTHELIN RECEPTOR ANTAGONISTS FOR THE PATIENT WITH IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION AND ATRIAL SEPTOSTOMY
by: V. V. Gramovich, et al.
Published: (2018-12-01)

COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AFTER THE STROKE
by: O. A. Ageenkova, et al.
Published: (2016-01-01)

Cardioselective beta-adrenoblocker bisoprolol in treating hypertensive patients with heart failure
by: A. N. Britov
Published: (2005-06-01)

EXPERIENCE OF USING THE NONSELECTIVE ENDOTHELIN RECEPTOR ANTAGONIST MACITENTAN IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION
by: M. A. Simakova, et al.
Published: (2018-04-01)

Efficacy and safety of glucagon-like peptide-1 receptor agonists therapy initiation in patients with type 2 diabetes hospitalized with coronavirus infection
by: T. N. Markova, et al.
Published: (2023-12-01)

Impact of GLP-1 receptor agonist-based therapies on cardiovascular and renal outcomes in diabetic and non-diabetic patients with CKD
by: Aliona Siniukovich, et al.
Published: (2025-07-01)

COMBINATION OF ACE INHIBITOR WITH AGONIST OF I1 -IMIDAZOLINE RECEPTORS: NEW OPPORTUNITIES FOR ANTIHYPERTENSIVE THERAPY
by: S. V. Nedogoda
Published: (2016-12-01)

CASE REPORT ON THE SUCCESSFUL USE OF A NEW SELECTIVE PROSTACYCLIN IP RECEPTOR AGONIST, SELEXIPAG, IN A PATIENT WITH IDIOPATHIC PULMONARY HYPERTENSION
by: Z. S. Valieva, et al.
Published: (2019-12-01)

Comparison of platelet hemostasis effects for angiotensin receptor blockers in patients with arterial hypertension and metabolic syndrome
by: I. N. Medvedev, et al.
Published: (2007-08-01)

Thrombopoietin Receptor Agonists: Clinical Use and Evaluation of Treatment Efficacy
by: A. G. Solodovnikov, et al.
Published: (2020-12-01)

Spirapril therapy and its effects in arterial hypertension patients
by: M. V. Leonova, et al.
Published: (2006-02-01)

COMPARATIVE EFFICIENCY OF THE COMBINED THERAPY IN PATIENT’S WITH ARTERIAL HYPERTENSION
by: V. V. Shchekotov, et al.
Published: (2014-07-01)

Theory and practice of selective imidazoline receptor agonist use in Russia
by: N. I. Gaponova, et al.
Published: (2024-07-01)

Antihypertensive therapy in obese patients with arterial hypertension
by: О. M. Drapkina, et al.
Published: (2009-08-01)

PLEIOTROPIC EFFECTS OF PARATHYROIDECTOMY AND AGONIST CALCIUM-SENSITIVE RECEPTOR, CINACALCET
by: L. V. Egshatyan, et al.
Published: (2015-09-01)

AMLODIPINE ADVANTAGES IN ARTERIAL HYPERTENSION THERAPY
by: V. M. Tsareva, et al.
Published: (2016-01-01)

Efficacy of Tirzepatide Dual GIP/GLP‐1 Receptor Agonist in Patients With Idiopathic Intracranial Hypertension. A Real‐World Propensity Score‐Matched Study
by: Ahmed Y. Azzam, et al.
Published: (2025-03-01)

DANGER OF ALCOHOL FOR PATIENTS WITH ARTERIAL HYPERTENSION DURING ANTIHYPERTENSIVE THERAPY
by: M. P. Savenkov, et al.
Published: (2016-01-01)

METABOLIC EFFECTS OF ALTIAZEM-PP, A PROLONGED CALCIUM ANTAGONIST, IN PATIENTS WITH MILD ARTERIAL HYPERTENSION
by: I. A. Tvaladze, et al.
Published: (2001-08-01)

CHOICE OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND CHRONIC LIVER DISEASES
by: M. N. Mamedov, et al.
Published: (2016-01-01)

Imidazoline receptor agonists: more than blood pressure reduction?
by: D. V. Nebieridze, et al.
Published: (2006-04-01)

RISK FACTORS OF ARTERIAL HYPERTENSION IN ORGANIZED COHORT OF MALE EMPLOYEES OF THE MACHINE BUILDING PLANT
by: A. N. Britov, et al.
Published: (2017-12-01)

New ways to arterial hypertension therapy in pregnancy time
by: A. V. Barabashkina, et al.
Published: (2005-06-01)

Should thrombopoietin receptor agonists be used for chemotherapy-induced thrombocytopenia?
by: Hanny Al-Samkari
Published: (2025-07-01)

Indapamide retard in complex therapy of patients with chronic heart failure and arterial hypertension
by: S. N. Tereshchenko, et al.
Published: (2010-04-01)

Characterization of Fatty Acid Photodecarboxylase in Zeolitic Imidazolate Frameworks
by: Min-Shih Su, et al.
Published: (2025-08-01)

PROSPECTS OF Toll-LIKE RECEPTOR AGONISTS AND ANTAGONISTS FOR PREVENTION AND TREATMENT OF VIRAL INFECTIONS
by: A. A. Nikonova, et al.
Published: (2019-07-01)

Indapamide therapy in elderly patients with arteriD al hypertension
by: G. G. Efremushkin, et al.
Published: (2005-10-01)